SIGN UP
LOG IN
MARKET
TRIB
TRIB
Trinity Biotech Plc
NASDAQ
1.910
+0.050
+2.69%
After Hours: 1.850 -0.06 -3.14% 16:00 04/15 EDT
OPEN
1.840
PREV CLOSE
1.860
HIGH
1.915
LOW
1.840
VOLUME
5.28K
TURNOVER
0
52 WEEK HIGH
6.20
52 WEEK LOW
1.810
MARKET CAP
14.60M
P/E (TTM)
-0.6087
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TRIB last week (0408-0412)?
Weekly Report · 21h ago
Weekly Report: what happened at TRIB last week (0401-0405)?
Weekly Report · 04/08 09:29
Trinity Biotech Accelerates Transformation and Growth
TipRanks · 04/05 17:27
TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023
Trinity Biotech reported earnings per share of -72 cents for the fourth quarter of 2023. The company reported revenue of $13.43 million. This was 10.48% worse than the analyst estimate for revenue. Trinity Biotech is a biotechnology company.
Investorplace · 04/04 15:52
Trinity Biotech Says It Is Targeting Approximately $20M Of Annualized Run-rate EBITDA On Annualized Run-rate Revenues Of Approximately $75M By Q2, 2025
Benzinga · 04/04 11:45
Trinity Biotech Q4 EPS $(0.72) Up From $(1.33) YoY, Sales $13.43M Miss $15.00M Estimate
Trinity Biotech reported quarterly losses of $0.72 per share. The company reported quarterly sales of $13.43 million which missed the analyst consensus estimate of $15.00 million. Trinity Biotech also reported a 45.86 percent increase in sales from the same period last year.
Benzinga · 04/04 11:42
Trinity Biotech reports Q4 results
Seeking Alpha · 04/04 11:33
TRINITY BIOTECH - ANNOUNCING AN INITIATIVE TO MOVE SIGNIFICANT ASPECTS OF OUR BUSINESS SUPPORT FUNCTIONS TO A LOWER COST AND CENTRALISED LOCATION
Reuters · 04/04 11:30
About TRIB
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
Webull offers Trinity Biotech plc (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.